Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s41467-021-26548-6
| Title: | PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019) | Authors: | Thura, Min Al-Aidaroos, Abdul Qader Gupta, Abhishek Chee, Cheng Ean Lee, Soo Chin Hui, Kam Man Li, Jie Guan, Yeoh Khay Yong, Wei Peng So, Jimmy Chng, Wee Joo Ng, Chin Hin Zhou, Jianbiao Wang, Ling Zhi Yuen, John Shyi Peng Ho, Henry Sun Sien Yi, Sim Mei Chiong, Edmund Choo, Su Pin Ngeow, Joanne Ng, Matthew Chau Hsien Chua, Clarinda Yeo, Eugene Shen Ann Tan, Iain Bee Huat Sng, Joel Xuan En Tan, Nicholas Yan Zhi Thiery, Jean Paul Goh, Boon Cher Zeng, Qi |
Keywords: | Science & Technology Multidisciplinary Sciences Science & Technology - Other Topics |
Issue Date: | 2-Nov-2021 | Publisher: | NATURE PORTFOLIO | Citation: | Thura, Min, Al-Aidaroos, Abdul Qader, Gupta, Abhishek, Chee, Cheng Ean, Lee, Soo Chin, Hui, Kam Man, Li, Jie, Guan, Yeoh Khay, Yong, Wei Peng, So, Jimmy, Chng, Wee Joo, Ng, Chin Hin, Zhou, Jianbiao, Wang, Ling Zhi, Yuen, John Shyi Peng, Ho, Henry Sun Sien, Yi, Sim Mei, Chiong, Edmund, Choo, Su Pin, Ngeow, Joanne, Ng, Matthew Chau Hsien, Chua, Clarinda, Yeo, Eugene Shen Ann, Tan, Iain Bee Huat, Sng, Joel Xuan En, Tan, Nicholas Yan Zhi, Thiery, Jean Paul, Goh, Boon Cher, Zeng, Qi (2021-11-02). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019). NATURE COMMUNICATIONS 12 (1). ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-021-26548-6 | Abstract: | In this article the funding from ‘Open Fund-Individual Research Grant (OF-IRG), National Medical Research Council (NMRC) Singapore with the project ID of NMRC/OFIRG/0053/2017’ was omitted. | Source Title: | NATURE COMMUNICATIONS | URI: | https://scholarbank.nus.edu.sg/handle/10635/208517 | ISSN: | 20411723 | DOI: | 10.1038/s41467-021-26548-6 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| PRL3zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.Thura et al.NatComm.2019.pdf | 4.56 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.